GlassScriptPhysician profile
Michelle Felden
NPI 1801538608
$296.99
in general payments reported to CMS, 2019-2025
7 companies · $202 in 2025
The $202 reported for 2025 was more than what 75% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $59.55 · 2024: $35.84 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163 · Education: $125 · Gift: $8.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.29 |
| Education | $125.00 |
| Gift | $8.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $168.36 | 2025 | Invisalign |
| Orapharma, A Division of Bausch Health US, LLC | $35.84 | 2024 | Arestin, Ossix Plus |
| Envista Holdings Corporation | $33.24 | 2025 | Endodontics |
| Kerr Corporation | $15.63 | 2023 | Harmonize |
| Nobel Biocare USA | $15.62 | 2023 | Nobelactive |
| Philips North America LLC | $15.09 | 2023 | |
| 3m Company | $13.21 | 2023 | Filtek, Scotchbond Universal Plus, 3m Espe Filtek Supreme Ultra Universal Restorative |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Felden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.